๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Kuros Biosciences AG (SWX:KURN)
Switzerland flag Switzerland ยท Delayed Price ยท Currency is CHF
18.78
-0.60 (-3.10%)
Nov 20, 2026, 5:30 PM CET

Kuros Biosciences AG Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
174.93146.0685.1639.8619.4515.15
Revenue Growth
19.77%71.51%113.65%104.92%28.35%231.96%
Gross Profit
154.34127.4575.6733.8115.5411.04
Operating Income
10.628.950.12-6.04-10.65-9.62
Net Income
8.972.55-4.84-16.3-15.78-8.27
Earnings Per Share
0.220.06-0.13-0.45-0.47-0.25
EPS Growth
250.42%-----

Revenue by Geography

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States of America
170.09140.9482.13918.814.5
European Union
3.653.110.840.690.460.31
Other
1.192.012.220.170.190.35
Total
174.93146.0685.1639.8619.4515.15

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9.7319.7719.7616.8726.0331.4
Total Debt
10.071.391.972.542.072.43
Net Cash (Debt)
-0.3318.3817.814.3323.9628.97
Net Cash Growth
-3.28%24.20%-40.19%-17.31%-1.34%
Net Cash Per Share
-0.010.440.480.390.710.88

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.62-0.463.54-10.5-7.95-5.99
Capital Expenditures
-8.09-2.44-1.23-0.38-0.43-0.33
Free Cash Flow
-8.72-2.892.31-10.88-8.37-6.32
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
88.23%87.26%88.85%84.83%79.89%72.86%
Operating Margin
6.07%6.13%0.14%-15.15%-54.74%-63.46%
Pretax Margin
6.15%3.43%-4.43%-29.13%-88.91%-69.16%
Profit Margin
5.13%1.75%-5.68%-40.90%-81.15%-54.59%
FCF Margin
-4.98%-1.98%2.71%-27.29%-43.05%-41.72%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
106.72531.92----
Forward PE
52.0280.23----
P/FCF Ratio
--385.54---
PS Ratio
5.299.2910.443.822.994.57